In consultation: Guidance and quality standards
Showing 11 to 13 of 13
| Title | Consultation | Type | Consultation end date |
|---|---|---|---|
| Rebisufligene etisparvovec for treating mucopolysaccharidosis type IIIA [ID6540] | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance | |
| Elamipretide for treating Barth syndrome in people of any age [ID6545] | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance | |
| Povorcitinib for treating moderate to severe active hidradenitis suppurativa after a TNF-alpha inhibitor [ID6569] | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance |